期刊文献+

癌性胸、腹腔积液的蛋白质提取及静脉回输研究 被引量:2

The Study of Isolating Protein from Malignant Hydrothorax and Ascites and Infusing Auto-protein Vein
下载PDF
导出
摘要 目的:探索癌性胸、腹腔积液蛋白质的提取方法,并对自体蛋白静脉回输后的临床疗效进行观察,从而为癌 性胸、腹积液中蛋白质的再利用提供实验依据。方法:采用透析、冷凝低速离心、变速离心和抽滤等技术对癌性积液中的蛋白 质进行分离提取。结果:该方法提取的蛋白质的浓缩倍数可达9.78倍,回收率为54.75%;蛋白质分离提取前后离子K+、 Na+、Cl-浓度均无明显差异(P>0.05),而BIL、IL 2、IL 4、IFN和TNF的浓度明显增加(P<0.05),患者自体蛋白液回输后无 发热、过敏等副反应发生,同时水肿也得到一定程度的控制,除CD+4细胞百分率和CD+4/CD+8比值明显增加外(P<0.05), CD+3、CD+8细胞百分率、总蛋白及IgG浓度均无明显改变(P>0.05)。结论:通过透析、变速离心及抽滤等技术,可从癌性胸、 腹腔积液中浓缩分离出适合静脉输注的蛋白质提取液。 Objective:To explore the method by which protein was isolated from malignant hydrothorax or ascites and the clinical effect of auto-protein infused in vein,which could provide experiment evidence for the further study of the utilization of protein isolated from malignant hydrothorax or ascites.Methods:The protein contained in malignant hydrothorax and ascites was isolated and abstracted by dialysis,centrifuge and filtration.Results:The inspissation multiple of protein in the isolated and distilled course was 9.78 times,the rate of protein recovery is 54.75%:The ion concentrations of K +、Na +、Cl - have not distinct difference during the protein was isolated(P>0.05),but the concentration of BIL,IL-1,IL-4,IFN,TNF increased greatly(P<0.05).After the infusion of auto-protein,except CD 4 + and the rat of CD 4 +/CD 8 + increased(P<0.05),the concentrations of TB and IgG had not been changed,along with the percentage of CD 3 and CD 8 positive cells(P>0.05).Conclusion:Through the technique of dialysis,centrifuge and filtration,protein suit to infuse in vein could be isolated.
出处 《临床肿瘤学杂志》 CAS 2005年第1期36-39,42,共5页 Chinese Clinical Oncology
关键词 癌性 腹腔积液 静脉回输 蛋白质提取 自体 透析 CD4^+细胞 CD3^+ CD4^+/CD8^+ CD8^+细胞 Autologous Infuse Malignant tumor Hydrothorax and Ascites
  • 相关文献

参考文献11

  • 1蒋敬庭,吴昌平,吴爱珍,陈国瑾,孙文辉,陈雪勤.TIL治疗癌性胸水的疗效观察[J].中国肿瘤临床,1999,26(3):226-226. 被引量:10
  • 2冯玉梅,毛慧生,苏明秀,王殿昌,卢虹,马维东.恶性胸腹水自体蛋白的制备及回输[J].中国肿瘤临床,1997,24(11):831-834. 被引量:11
  • 3何山林,徐宏君,王学敬.胸水静脉回输治疗顽固性肝性胸水16例[J].临床肝胆病杂志,1999,15(3):192-192. 被引量:7
  • 4卢锦汉.医学生物制剂学[M].北京:人民出版社,1995.813-845.
  • 5张伯伦.腹水直接回输中不良反应观察[J].实用内科杂志,1989,7:352-352.
  • 6王申生.自体腹水浓缩静脉回输治疗肝硬化腹水[J].中国实用内科杂志,1986,(9):467-467.
  • 7王怀瑾,张阳,刘艳娥,张淑芝,赵久阳,沙丽艳,王淑岩.癌性腹水超滤浓缩自体腹腔回输的临床研究[J].大连医科大学学报,1999,21(3):183-186. 被引量:11
  • 8李瑞林 丁涛 等.自体腹水离心静脉回输术治疗实验性腹水型肝癌[J].实用肿瘤学杂志,1987,(3):10-10.
  • 9Antin AD, Bellone S, RavaggiA,et al. Increased levels of Interleakin-10 and transforming growth facor-β in the plasnm and ascitic fluid of patients,2001,108(8) :804 -808.
  • 10Sato I, Sato S, Aoki A. Treatment of cancer patients with a biological response modifier obtained from ascites of cancer patients during regression of the tumors [ J ]. XVI International Cancer Congress, 1994 : p2743.

二级参考文献5

共引文献37

同被引文献29

引证文献2

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部